Vaxxinity and University of Florida collaborate on research supporting neurodegenerative disease immunotherapies
Jan. 31, 2024
Vaxxinity Inc. has announced a research collaboration with the University of Florida’s (UF) Center for Translational Research in Neurodegenerative Disease (CTRND) to support its work on the development of vaccines for neurodegenerative diseases.